nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—chronic obstructive pulmonary disease	0.753	1	CbGaD
Sodium lauryl sulfate—ALB—Prednisone—chronic obstructive pulmonary disease	0.0379	1	CbGbCtD
Sodium lauryl sulfate—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.000822	0.00393	CcSEcCtD
Sodium lauryl sulfate—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000819	0.00392	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.000813	0.00388	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.000805	0.00385	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000803	0.00384	CcSEcCtD
Sodium lauryl sulfate—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000794	0.0038	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00376	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000783	0.00374	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.000776	0.00371	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000761	0.00364	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000757	0.00362	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000757	0.00362	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000751	0.00359	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000751	0.00359	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000747	0.00357	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000747	0.00357	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000706	0.00337	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.000701	0.00335	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000696	0.00332	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000692	0.00331	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000687	0.00329	CcSEcCtD
Sodium lauryl sulfate—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.000683	0.00327	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.00324	CcSEcCtD
Sodium lauryl sulfate—Abscess—Prednisone—chronic obstructive pulmonary disease	0.000678	0.00324	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000667	0.00319	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000664	0.00317	CcSEcCtD
Sodium lauryl sulfate—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000662	0.00316	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000655	0.00313	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000652	0.00312	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.0031	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000643	0.00307	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000639	0.00305	CcSEcCtD
Sodium lauryl sulfate—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000635	0.00303	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000633	0.00303	CcSEcCtD
Sodium lauryl sulfate—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.003	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.003	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000623	0.00298	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000611	0.00292	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.00292	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000609	0.00291	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00291	CcSEcCtD
Sodium lauryl sulfate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000604	0.00289	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000603	0.00288	CcSEcCtD
Sodium lauryl sulfate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000602	0.00288	CcSEcCtD
Sodium lauryl sulfate—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0006	0.00287	CcSEcCtD
Sodium lauryl sulfate—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000598	0.00286	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.00285	CcSEcCtD
Sodium lauryl sulfate—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000593	0.00283	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000591	0.00282	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000588	0.00281	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000583	0.00279	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000583	0.00279	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00276	CcSEcCtD
Sodium lauryl sulfate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000569	0.00272	CcSEcCtD
Sodium lauryl sulfate—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000567	0.00271	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00265	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000554	0.00265	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.00263	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000541	0.00259	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000526	0.00252	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000526	0.00252	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000522	0.0025	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000516	0.00246	CcSEcCtD
Sodium lauryl sulfate—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00246	CcSEcCtD
Sodium lauryl sulfate—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000509	0.00243	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000507	0.00243	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00242	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00242	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000505	0.00242	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000505	0.00242	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000505	0.00242	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00241	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00241	CcSEcCtD
Sodium lauryl sulfate—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00241	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000497	0.00238	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000495	0.00237	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00236	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00235	CcSEcCtD
Sodium lauryl sulfate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00232	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00232	CcSEcCtD
Sodium lauryl sulfate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00232	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00232	CcSEcCtD
Sodium lauryl sulfate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000483	0.00231	CcSEcCtD
Sodium lauryl sulfate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000483	0.00231	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00229	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00229	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000477	0.00228	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.00228	CcSEcCtD
Sodium lauryl sulfate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00228	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00228	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00227	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00227	CcSEcCtD
Sodium lauryl sulfate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000473	0.00226	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000471	0.00225	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.00223	CcSEcCtD
Sodium lauryl sulfate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00222	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00219	CcSEcCtD
Sodium lauryl sulfate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00219	CcSEcCtD
Sodium lauryl sulfate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.00218	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000454	0.00217	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000454	0.00217	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00216	CcSEcCtD
Sodium lauryl sulfate—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00216	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.00216	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00214	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00212	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00212	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00209	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00209	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.00207	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000433	0.00207	CcSEcCtD
Sodium lauryl sulfate—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000429	0.00205	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00205	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000428	0.00204	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00204	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000422	0.00202	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000419	0.002	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.002	CcSEcCtD
Sodium lauryl sulfate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00199	CcSEcCtD
Sodium lauryl sulfate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00199	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00197	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00196	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00196	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00195	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00194	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000405	0.00193	CcSEcCtD
Sodium lauryl sulfate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00193	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000402	0.00192	CcSEcCtD
Sodium lauryl sulfate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0004	0.00191	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00191	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.0019	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.0019	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000398	0.0019	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00189	CcSEcCtD
Sodium lauryl sulfate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00188	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000389	0.00186	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00185	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00185	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00184	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00184	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00184	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00184	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00183	CcSEcCtD
Sodium lauryl sulfate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00182	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000379	0.00181	CcSEcCtD
Sodium lauryl sulfate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000379	0.00181	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000378	0.00181	CcSEcCtD
Sodium lauryl sulfate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.0018	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000376	0.0018	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000376	0.0018	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00179	CcSEcCtD
Sodium lauryl sulfate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000372	0.00178	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00174	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00173	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00173	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00171	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00171	CcSEcCtD
Sodium lauryl sulfate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.00171	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000354	0.00169	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00168	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00167	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00167	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00164	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00164	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00163	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00162	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00162	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00161	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00159	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00159	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00158	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000329	0.00157	CcSEcCtD
Sodium lauryl sulfate—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000328	0.00157	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00156	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00155	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000321	0.00154	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.00154	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00151	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.0015	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00148	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00148	CcSEcCtD
Sodium lauryl sulfate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00147	CcSEcCtD
Sodium lauryl sulfate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00147	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00146	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00146	CcSEcCtD
Sodium lauryl sulfate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00146	CcSEcCtD
Sodium lauryl sulfate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00146	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00145	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00145	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000303	0.00145	CcSEcCtD
Sodium lauryl sulfate—Rash—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00144	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00143	CcSEcCtD
Sodium lauryl sulfate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000298	0.00143	CcSEcCtD
Sodium lauryl sulfate—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000296	0.00141	CcSEcCtD
Sodium lauryl sulfate—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00141	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.0014	CcSEcCtD
Sodium lauryl sulfate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00138	CcSEcCtD
Sodium lauryl sulfate—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000289	0.00138	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00138	CcSEcCtD
Sodium lauryl sulfate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00138	CcSEcCtD
Sodium lauryl sulfate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00138	CcSEcCtD
Sodium lauryl sulfate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.00137	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.00136	CcSEcCtD
Sodium lauryl sulfate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.00135	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000279	0.00134	CcSEcCtD
Sodium lauryl sulfate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.0013	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00126	CcSEcCtD
Sodium lauryl sulfate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.00126	CcSEcCtD
Sodium lauryl sulfate—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00124	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00123	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00122	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.00115	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00113	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00106	CcSEcCtD
Sodium lauryl sulfate—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00021	0.001	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.001	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000985	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000971	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000951	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.000927	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000915	CcSEcCtD
Sodium lauryl sulfate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000915	CcSEcCtD
Sodium lauryl sulfate—Infection—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000909	CcSEcCtD
Sodium lauryl sulfate—Shock—Prednisone—chronic obstructive pulmonary disease	0.000188	0.0009	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000893	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000884	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000872	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000832	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000821	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000795	CcSEcCtD
Sodium lauryl sulfate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000793	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000793	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000788	CcSEcCtD
Sodium lauryl sulfate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000788	CcSEcCtD
Sodium lauryl sulfate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000782	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000748	CcSEcCtD
Sodium lauryl sulfate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000748	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000726	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000723	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000723	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000674	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000656	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000647	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000626	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000605	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000581	CcSEcCtD
Sodium lauryl sulfate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000577	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000576	CcSEcCtD
Sodium lauryl sulfate—Headache—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000573	CcSEcCtD
Sodium lauryl sulfate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000543	CcSEcCtD
